Effectiveness of Sulfadoxine–Pyrimethamine for Intermittent Preventive Treatment of Malaria and Adverse Birth Outcomes in Pregnant Women
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine (IPTp-SP) for prevention of malaria and adverse birth outcomes can be compromised by parasites-resistance to sulfadoxine–pyrimethamine. This study prospectively evaluated the effectiveness of IPTp-SP in Southeast Tanzania. From January 2017 to May 2019, HIV-negative and malaria-negative (mRDT) pregnant women attending their first antenatal-care visit in the second or third trimester (n = 500) were enrolled to receive monthly IPTp-SP and followed the protocol till delivery. The primary outcome was the prevalence of histopathological placental malaria. Secondary outcomes were anemia, malaria parasites detected during pregnancy and at delivery, adverse birth outcomes (low-birth-weight [LBW], premature birth, fetal anemia, still birth, and spontaneous abortion). Rates of histopathological placental malaria, any parasitemia at delivery (placental, cord or maternal), and any adverse birth outcome were 9.4%, 20.9%, and 26.5%, respectively. Rates of symptomatic malaria and parasitemia during pregnancy were 2.8% and 16%, respectively. Histopathological placental malaria significantly increased the odds of any adverse birth outcomes, particularly LBW. IPTp-SP with more than or equal to three doses significantly improved birth weight and reduced the risk of LBW by 56% compared to <3 SP doses (p = 0.009). IPTp-SP with more than or equal to three doses is still effective in improving birth weight. However, the detection of histopathological placental-malaria in one-tenth and parasitemia in one-fifth of pregnant women reflects the need to optimize the prevention of malaria during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have demonstrated that IPTp-SP can reduce the prevalence of maternal P.falciparum infection, low birth weight and preterm birth, particularly in women in their first and second pregnancies [21, 145–147]”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [147]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In HIV-negative women, IPTp-SP with three or more doses has been shown to significantly improve birth weight and reduce the risk of low birth weight by 56% compared to fewer than three doses [147].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [147]
The cited source says what the claim attributes to it.
In the citing paper
“The efficacy of this measure can be compromised by parasite resistance to SP [147].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604
Quantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study
Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W., & ter Kuile, F. O. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000221 · Cited by 490
A strategic framework for malaria prevention and control during pregnancy in the African region
Ntirushwa, D. (2010) · Cited by 340
Kayentao, K., Garner, P., Maria van Eijk, A., Naidoo, I., Roper, C., Mulokozi, A., MacArthur, J. R., Luntamo, M., Ashorn, P., Doumbo, O. K., et al. (2013) · JAMA · doi:10.1001/jama.2012.216231 · Cited by 298
Mapping ‘partially resistant’, ‘fully resistant’, and ‘super resistant’ malaria
Naidoo, I., & Roper, C. (2013) · Trends in Parasitology · doi:10.1016/j.pt.2013.08.002 · Cited by 228
Dimasuay, K. G., Aitken, E. H., Rosario, F., Njie, M., Glazier, J., Rogerson, S. J., Fowkes, F. J. I., Beeson, J. G., Powell, T., Jansson, T., et al. (2017) · BMC Medicine · doi:10.1186/s12916-016-0759-3 · Cited by 189
Quakyi, I., Tornyigah, B., Houze, P., Kusi, K. A., Coleman, N., Escriou, G., Laar, A., Cot, M., Fobil, J., Asare, G. Q., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55046-5 · Cited by 183
Effects of routine oral iron supplementation with or without folic acid for women during pregnancy
Peña-Rosas, J. P., & Viteri, F. E. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004736.pub2 · Cited by 182
Desai, M., Gutman, J., Taylor, S. M., Wiegand, R. E., Khairallah, C., Kayentao, K., Ouma, P., Coulibaly, S. O., Kalilani, L., Mace, K. E., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ881 · Cited by 174 · cited 3×
“Similar studies have reported dose-dependent IPTp-SP impact on birth weight [11,30,35].”
ResultInfluentialHarrington, W. E., Mutabingwa, T. K., Kabyemela, E., Fried, M., & Duffy, P. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir376 · Cited by 156 · cited 1×
“In a study done in the northeast of Tanzania, the use IPTp-SP was associated with decreased cord blood hemoglobin and increased the risk of fetal anemia, which was hypothesized to be due to in utero SP exposure, thus suppressing fetal hematopoiesis [40].”
Background
Cited by
Chua, C. L. L., Hasang, W., Rogerson, S. J., & Teo, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621382 · Cited by 113
Mlugu, E. M., Minzi, O., Kamuhabwa, A. A. R., & Aklillu, E. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17093123 · Cited by 55
Self-citationCurrent update on malaria in pregnancy: a systematic review
Minwuyelet, A., Yewhalaw, D., Siferih, M., & Atenafu, G. (2025) · Tropical Diseases, Travel Medicine and Vaccines · doi:10.1186/s40794-025-00248-1 · Cited by 49
Mlugu, E. M., Minzi, O., Kamuhabwa, A. A. R., & Aklillu, E. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2273 · Cited by 35
Self-citationDosoo, D., Malm, K., Oppong, F. B., Gyasi, R. K., Oduro, A. R., Williams, J. E., Atibilla, D., Peprah, N. Y., Twumasi, M. F., Owusu‐Agyei, S., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-005877 · Cited by 36
Metadata
- Authors
- Mlugu, E. M., Minzi, O., Asghar, M., Färnert, A., Kamuhabwa, A. A. R., & Aklillu, E.
- Affiliations
- Karolinska University Hospital (SE)
- Muhimbili University of Health and Allied Sciences (TZ)
- Corresponding author
- Aklillu, Eleni
- ORCID
- Venue
- Pathogens
- Publisher
- MDPI AG
- Published
- 2020-03-11
- Volume
- 9
- Issue
- 3
- Pages
- 207
- ISSN
- 2076-0817 (ISSN-L)
- PMC
- PMC7157612
- OpenAlex
- W3010728375
- Cited by
- 25
- References
- 41
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 2
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Styrelsen för Internationellt Utvecklingssamarbete (51170072)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- sulfadoxine-pyrimethamine, intermittent preventive treatment in pregnancy, malaria in pregnancy, adverse birth outcomes, low birth weight, placental malaria, antimalarial drug resistance, parasitemia, fetal anemia, stillbirth, miscarriage, anemia in pregnancy, dose number
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.